The I-KAN Study demonstrates the feasibility and safety of an innovative Internet-based education model for insulin management in Type 2 Diabetes patients, particularly in rural areas. Given the increasing prevalence of diabetes and the need for effective management solutions, this model could represent a significant opportunity for healthcare providers and digital health companies. The findings may support further development of telehealth solutions and educational platforms, potentially leading to partnerships with pharmaceutical companies that manufacture insulin products. The study's outcomes could also influence reimbursement policies for digital health interventions, enhancing market access for similar future initiatives.